Found vs Henry Meds 2026: GLP-1 Weight Loss Programs Compared

Found vs Henry Meds vs Trimi: Complete Comparison

Note: Prices were re-checked on 29 September 2026 on each provider's own site (Found's plans and store pages, Henry Meds' programs page). None of the three raises its price as your dose rises; each varies by plan length instead. Found bills per 28-day cycle, so a year of month-to-month billing is 13 charges. Found's insurance track costs less per cycle, plus a video-visit copay that Found says is typically around $30.

Pricing Analysis: The Real Cost Over 12 Months

Comparing monthly rates tells only part of the story, because all three providers price semaglutide and tirzepatide by plan length rather than by dose. Found bills per 28-day cycle, so a year of month-to-month billing is 13 charges rather than 12. Henry Meds' lowest semaglutide rate requires paying twelve months in full, and its multi-month plans may require paying the remaining balance if you stop early. Trimi's lowest rates are its annual-plan prices, a 12-month commitment.

The annual cost difference is substantial. On the longest cash-pay plans, a year of semaglutide costs $2,028 or more at Found ($169 per 28-day cycle) and $2,364 at Henry Meds (twelve months paid in full). Trimi's annual plan costs $1,188, at least $840 less than Found and $1,176 less than Henry Meds. Month to month, the gap is wider: Found charges $289 per cycle after the first and Henry Meds charges $297 per month, while Trimi's month-to-month semaglutide plan is $175. These differences compound over the multi-year treatment courses that many patients require for sustained weight management. Found's insurance track is priced differently: $99 per cycle for semaglutide on a 12-month plan, plus a copay for each required video visit.

Henry Meds' initial evaluation is free; its terms describe a $30 consultation fee for each provider evaluation that results in a prescription, collected as part of its bundled billing. Found includes clinical care in its plan price. Trimi charges no consultation fee. For detailed pricing analysis, see our cheapest GLP-1 injections guide.

Medications and Coaching: What Each Provider Offers

Medication Options

Both Found and Henry Meds prescribe compounded semaglutide, and both list compounded tirzepatide in some form (Found as a weekly injection, Henry Meds as oral dissolving tablets), prepared by state-licensed compounding pharmacies. The active pharmaceutical ingredient is identical across providers. A milligram of semaglutide from Found is pharmacologically indistinguishable from a milligram of semaglutide from Henry Meds or Trimi. The medication acts on GLP-1 receptors in the same way, produces the same appetite suppression, and carries the same side effect profile regardless of which platform prescribes it.

Tirzepatide, a dual GIP/GLP-1 receptor agonist, is available as a weekly compounded injection from Found and Trimi; Henry Meds lists it only as oral dissolving tablets. In the SURMOUNT-1 trial, tirzepatide produced up to 22.5 percent body weight loss at the highest dose over 72 weeks (Jastreboff et al., NEJM, 2022). Found charges $239 to $359 per 28-day cycle for compounded tirzepatide on cash pay. Henry Meds does not list an injectable tirzepatide price. Trimi offers tirzepatide at $125 per month on its annual plan, with flat dose-independent pricing.

Coaching and Behavioral Support

This is where Found and Henry Meds diverge most significantly. Found integrates behavioral coaching into its platform through app-based tools, meal tracking, community forums, and provider-guided lifestyle programming. The coaching is designed around behavioral science principles, helping patients build sustainable habits around nutrition, physical activity, and mindset. Found's coaching model appeals to patients who want structured support alongside their medication.

Henry Meds does not offer coaching, behavioral tools, meal tracking, or community features. Their model is explicitly medication-focused: get a prescription from a licensed provider, receive compounded GLP-1 medication by mail, and manage your own lifestyle changes independently. For patients who are self-motivated and do not need external behavioral support, this streamlined approach is straightforward. For patients who benefit from accountability and structured guidance, the absence of coaching at Henry Meds is a meaningful gap.

Provider Access and Medical Oversight

Both Found and Henry Meds employ licensed medical providers who prescribe and monitor GLP-1 treatment. Found's provider interactions are supplemented by coaching touchpoints and app-based check-ins. Henry Meds offers standard telehealth provider consultations for prescription management and dose adjustments. Trimi provides responsive telehealth provider access with personalized clinical guidance. The core medical oversight, evaluating eligibility, prescribing medication, adjusting doses, monitoring for side effects, is functionally comparable across all three platforms.

Where Found Wins Over Henry Meds

Where Henry Meds Wins Over Found

Where Both Found and Henry Meds Fall Short

Clinical Evidence: What the Trials Show

The clinical evidence supporting GLP-1 medications for weight loss is extensive and applies equally to all providers prescribing these compounds. The medication's efficacy does not depend on where you fill the prescription, it depends on the pharmacological properties of the drug itself, patient adherence, dosing, and individual metabolic factors.

The critical implication for the found vs henry meds comparison is that the medication component is clinically equivalent across providers. A patient receiving compounded semaglutide from Found will experience the same pharmacological effects as a patient receiving compounded semaglutide from Henry Meds or Trimi. The differences between providers are entirely in pricing, ancillary services, and support models, not in medication efficacy or safety.

Side Effects: Identical Regardless of Provider

Because Found, Henry Meds, and Trimi prescribe the same active medications, the side effect profiles are identical. The most common side effects of semaglutide and tirzepatide include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These gastrointestinal effects are dose-dependent and typically most pronounced during the initial titration period, subsiding as the body adjusts to the medication over the first four to eight weeks.

More serious but rare side effects include pancreatitis, gallbladder disease, and potential thyroid concerns. Both the STEP 1 and SURMOUNT-1 trials documented these adverse events at low rates. Proper medical monitoring, available through all three providers, helps identify and manage side effects promptly. For detailed side effect information specific to each provider, see our guides on Found weight loss side effects and Henry Meds side effects.

The practical difference is in how each provider manages side effects. Found's coaching infrastructure may provide more frequent touchpoints for reporting and managing gastrointestinal symptoms through dietary adjustments. Henry Meds relies on standard telehealth visits for side effect management. Trimi offers responsive provider access for dose adjustments and side effect guidance. None of these approaches has been shown to be superior in clinical trials, side effect management is fundamentally about patient-provider communication and appropriate dose titration.

Cancellation Policies Compared

Cancellation flexibility matters because GLP-1 treatment is a long-term commitment that circumstances may require pausing or stopping. Henry Meds lets patients on monthly plans cancel any time from their account page, but its FAQ says patients on multi-month plans may be required to pay the rest of their balance unless they stop for medical reasons. Found's lowest prices come with 3, 6, or 12-month plans, and its 12-month plans are paid up front. Some Found patients report difficulty navigating the cancellation process.

If you are considering switching providers, our guides on how to cancel Found and how to cancel Henry Meds walk through the exact steps. Trimi's $99 and $125 prices are annual-plan rates, a 12-month commitment backed by a 6-month money-back policy (see the refund policy), and its month-to-month plan ($175 for semaglutide, $235 for tirzepatide) can be cancelled any time. Your medication dose and type transfer seamlessly when switching between providers.

Who Should Choose Which Provider?

The Bottom Line

Found and Henry Meds are both legitimate GLP-1 telehealth providers, but they serve different patient profiles. Found is the better choice for patients who want coaching and behavioral support as part of their weight loss program. Henry Meds is the better choice for patients who want simple, no-frills medication access. On cash pay, neither provider matches Trimi's annual-plan rates of $99 per month for semaglutide or $125 per month for tirzepatide.

The medication component is the same across all three providers, so the differences are entirely in pricing and ancillary services. For the majority of patients, the most rational approach is to start with the most affordable provider offering competent clinical oversight, and only upgrade to a coaching-intensive program if you find that medication alone is insufficient for your goals. That starting point, based on current pricing and service quality, is Trimi.